Emerging leader in infused innovations, BevCanna Enterprises (BevCanna) (CSE:BEV) announced today that it has been awarded an Industrial Hemp Cultivation License from Health Canada, pursuant to the Cannabis Act (Canada) (the “Hemp License”). This highly-coveted license is a significant step in BevCanna’s plan to launch a portfolio of CBD-infused beverages and other consumable products. BevCanna also anticipates the issuance of their Standard Processing and Research Licenses from Health Canada.

Securing this first license allows BevCanna to produce low-cost, high-quality, sungrown hemp biomass for extraction of cannabidiol (CBD), derived from their 100-acre outdoor cultivation site in the highly fertile Okanagan region of British Columbia. Extracted CBD is then infused into premium spring water, sourced from a pristine and naturally alkaline aquifer, to which BevCanna holds exclusive rights in partnership with Naturo Springs. The unique combination will be the basis for a range of innovative CBD beverage products, for both in-house brands and white-label clients.


“Our vision is to create a compelling portfolio of products that appeal to a wide variety of consumer tastes,” said Marcello Leone, CEO of BevCanna. “Consumers want choice in their CBD-infused products, and we plan to fill that gap in the market. Building on our decades of experience in developing, bottling and marketing premium quality beverages, we have the infrastructure and resources to develop quickly into a vertically-integrated operation. This puts us squarely on the path to becoming category leaders in the infused products landscape.”

“We’re also pleased that this license allows us to further expand our presence and identity as a B.C.-based company,” continued Leone. “We take great pride in our B.C. roots and we’ve continued to grow and bring prosperity to the region over the past ten years, through our Naturo Springs operation. This license enhances our ability to contribute in a meaningful and prosperous way to the B.C. economy.”

About BevCanna

BevCanna Enterprises Inc. (CSE:BEV) plans to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles. BevCanna’s vision is to be a global leader in infused innovations.

Contacts

For media enquiries or interviews: 
Wynn Theriault, Thirty Dash Communications
416-710-3370
wynn@thirtydash.ca

For investor inquiries: 
Luca Leone, BevCanna Enterprises Inc.
604-880-6618
luca@bevcanna.com

Click here to connect with Bevcanna Enterprises Inc. (CSE:BEV) for an Investor Presentation

Source: www.businesswire.com

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less